𝛼SK or Searchbullish
Eco Animal Health - ECOVAXXIN® MG receives US safety validation
SUMMARY
- Following the recent announcement of plans for commercialisation of ECOVAXXIN® MS, ECO Animal Health announces that the United States Department of Agriculture (USDA) has delivered a favourable safety assessment of ECOVAXXIN® MG, the Company’s live poultry vaccine targeting Mycoplasma gallisepticum.
- The USDA review and acceptance of ECOVAXXIN® MG safety data represents an important step towards securing marketing authorisation for the vaccine in the United States.
- EAH has estimated that ECOVAXXIN® MG has the potential to contribute peak revenue of c.£10.0m by 2036 as part of a portfolio of new products under development of which ECOVAXXIN® MG stands in the ‘late stage’, i.e. early contributor segment.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Eco Animal Health - ECOVAXXIN® MG receives US safety validation11 Mar 2026
x